Last reviewed · How we verify

Meningococcal (vaccine) — Competitive Intelligence Brief

Meningococcal (vaccine) (Meningococcal (vaccine)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bacterial polysaccharide conjugate vaccine. Area: Immunology / Infectious Disease.

marketed Bacterial polysaccharide conjugate vaccine Neisseria meningitidis capsular polysaccharides and outer membrane proteins Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Meningococcal (vaccine) (Meningococcal (vaccine)) — GlaxoSmithKline. The meningococcal vaccine stimulates the immune system to produce antibodies against Neisseria meningitidis, preventing meningococcal disease.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Meningococcal (vaccine) TARGET Meningococcal (vaccine) GlaxoSmithKline marketed Bacterial polysaccharide conjugate vaccine Neisseria meningitidis capsular polysaccharides and outer membrane proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Bacterial polysaccharide conjugate vaccine class)

  1. GlaxoSmithKline · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Meningococcal (vaccine) — Competitive Intelligence Brief. https://druglandscape.com/ci/meningococcal-vaccine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: